Loading data for IRMD — first visit, this takes a few seconds.

IRADIMED CORPORATION

NasdaqGM: IRMD · Real-Time Price · USD
87.00
-0.47 (-0.54%)
At close: Aug 27, 2026, 8:00 PM

The price, the headline numbers and the latest news, in one place.

IRADIMED CORPORATION (IRMD) Stock Price, Analysis & Data

-0.54%

No data available

Bid66.38
Market Cap1.11B
Revenue (ttm)86.34M
Net Income (ttm)23.05M
0.91
1.78
48.88
36.1
P/B (ttm)10.93
P/S (ttm)12.89
Earnings DateNov 3, 2026
Ask118.27
Volume76,199
Avg. Volume (20D)133,560
Open87.00
Previous Close87.47
Day's Range86.39 - 88.39
52-Week Range67.84 - 107.90
Analystn/a
Price Targetn/a
Dividends$0.8 (0.91%)
Ex-Dividend DateAug 14, 2026

About IRMD

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logg...

Sector Healthcare
IPO Date Jul 16, 2014
Employees 166
Stock Exchange NasdaqGM
Ticker Symbol IRMD
Full Company Profile

Financial Performance

In 2025, IRADIMED CORPORATION's revenue was 83.81M, an increase of 14.43% compared to the previous year's 73.24M. Earnings were 22.48M, an increase of 16.88%.

Financial Statements

Earnings Surprise

IRADIMED CORPORATION has released their quarterly earnings on Jul 31, 2026:
  • Revenue of $20.47M misses estimates by $0, with 0.28% YoY growth.
  • EPS of 0.46 exceeds estimates by 0.02, with -6.12% YoY decline.
IRADIMED CORPORATION is scheduled to release its earnings on Nov 3, 2026, before market opens.
Analysts project revenue of ... Upgrade